AI
| Followers | 842 |
| Posts | 122793 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Sunday, April 26, 2009 11:04:45 PM
INFORM-1 HCV Trial Design
INFORM-1 tests the combination of ITMN-191 (a protease inhibitor)
and R7128 (a nucleoside polymerase inhibitor) without either
interferon or ribavirin.
Note that two of the three latter cohorts are in the second-line
setting (for null and non-null responders, respectively, during
first-line treatment).
R7227 is an alternate name for ITMN-191.
INFORM-1 tests the combination of ITMN-191 (a protease inhibitor)
and R7128 (a nucleoside polymerase inhibitor) without either
interferon or ribavirin.
Note that two of the three latter cohorts are in the second-line
setting (for null and non-null responders, respectively, during
first-line treatment).
R7227 is an alternate name for ITMN-191.
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
